Últimas subidas - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 100 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 90 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 74 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Conversion to Wet AMD after Izervayvista 80 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 68 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 64 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 102 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 95 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 74 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 88 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 77 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 104 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 67 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 68 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 58 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 76 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 79 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 67 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 79 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 63 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 169 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 148 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 185 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 87 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 100 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 95 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 73 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 96 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 72 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 93 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 97 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 89 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 110 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 73 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 84 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 64 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 87 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 70 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 93 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 86 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 75 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 80 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 69 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 68 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 56 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 80 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 100 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 52 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 56 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 62 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 61 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 54 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 62 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 62 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 75 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 50 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 56 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 90 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 59 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 85 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 84 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 66 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 96 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 74 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 80 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 76 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 73 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 71 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 71 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 73 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 93 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 52 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 78 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 74 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 79 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 78 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 83 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 91 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 105 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 102 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 98 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 103 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 88 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 87 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 80 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 106 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 89 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 99 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 74 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 108 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 99 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 77 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 94 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Stable Myopic Tractional Maculopathyvista 119 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 113 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 109 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 100 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 117 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 106 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 103 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
| 2694 archivos en 27 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
